Blog
Understanding the Role of Selinexor in Treating Recurrent Glioblastoma: A Drug Safety Perspective
Glioblastoma (GBM) is the most common primary brain tumor in adults and is associated with a poor prognosis. The karyopherin exportin-1 (XPO1) is a nuclear export protein that plays a critical role in the transport of approximately 300 proteins from the nucleus to the...
Strengthening Critical Medicines
Decoding the MSSG’s New Recommendations The European Medicines Agency's Medicines Shortages Steering Group (MSSG) has developed recommendations to ensure the availability and supply of critical human medicines with identified supply chain vulnerabilities. Key...
REMS Requirements & How They Are Received by Patients and Caregivers
A qualitative study involving 63 participants examined their experiences with REMS (Risk Evaluation and Mitigation Strategies) programs associated with four specific drugs: Natalizumab, Riociguat, Sodium Pxybate, and Vigabatrin. While many participants found...
Chikungunya: What is it and Who Should Get Vaccinated?
What is Chikungunya (CHIKV)? Chikungunya Virus, also known as CHIKV, is a mosquito-borne viral disease that has been reported in over 110 countries. The name comes from the African Kimakonde language and roughly translates to, “To become contorted”, in...
Exploring COVID-19 Vaccine Effectiveness & Safety: Insights from Recent Studies
As the fight against COVID-19 continues, the efficacy and safety of vaccines remain critical considerations. Recent studies shed light on both fronts, offering valuable insights into vaccine effectiveness and potential adverse events. Vaccine Effectiveness in...
Unraveling the Narrative of Adverse Drug Reactions: A Patient-Centric Journey
In the labyrinth of modern medicine, adverse drug reactions (ADRs) stand as formidable challenges, often shrouded in mystery and uncertainty. For patients, navigating the landscape of ADRs can be daunting, with limited information available beyond the basics of nature...